Molecular Data Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '21 Jun 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Revenue	4,619	7,596	13,207	9,053	4,202	3,206
Revenue Growth (YoY)	-63.12%	-42.48%	45.88%	115.46%	31.06%	-
Cost of Revenue	4,622	7,607	13,107	8,973	4,152	3,180
Gross Profit	-2.68	-10.2	100.77	80.17	50.23	26.12
Selling, General & Admin	234.45	277.42	213.33	277.17	106.68	100.96
Research & Development	19.06	35.22	45.04	36.89	18.61	20.07
Operating Expenses	262.23	321.36	292.99	315.96	139.97	131.89
Operating Income	-264.91	-331.56	-192.21	-235.79	-89.73	-105.77
Interest Expense	-6.11	-10.73	-4.37	-19.05	-16.83	-8.44
Earnings From Equity Investments	-0.62	-0.65	-	-	-	-
Currency Exchange Gain (Loss)	9.01	5.46	0.19	-3.03	-0.55	-1.06
Other Non Operating Income (Expenses)	8.5	11.89	3.31	3.24	0.75	1.33
EBT Excluding Unusual Items	-254.13	-325.58	-193.08	-254.64	-106.36	-113.94
Gain (Loss) on Sale of Investments	-	-	-	-	-1.45	-
Pretax Income	-254.13	-325.58	-193.08	-254.64	-107.81	-113.94
Income Tax Expense	1.49	2.46	0.47	-	-	-
Earnings From Continuing Operations	-255.62	-328.04	-193.55	-254.64	-107.81	-113.94
Minority Interest in Earnings	-0.21	0.04	-	-	-	-
Net Income	-255.83	-328	-193.55	-254.64	-107.81	-113.94
Net Income to Common	-255.83	-328	-193.55	-254.64	-107.81	-113.94
Shares Outstanding (Basic)	10	8	7	7	7	7
Shares Outstanding (Diluted)	10	8	7	7	7	7
Shares Change (YoY)	-	12.08%	-	-	-	-
EPS (Basic)	-25.83	-42.39	-28.04	-36.89	-15.62	-16.51
EPS (Diluted)	-25.83	-42.39	-28.04	-36.90	-15.62	-16.51
Free Cash Flow	-	-234.05	-96.67	-135.12	-187.24	-148.16
Free Cash Flow Per Share	-	-30.25	-14.01	-19.57	-27.13	-21.46
Gross Margin	-0.06%	-0.13%	0.76%	0.89%	1.20%	0.81%
Operating Margin	-5.73%	-4.37%	-1.46%	-2.60%	-2.14%	-3.30%
Profit Margin	-5.54%	-4.32%	-1.47%	-2.81%	-2.57%	-3.55%
Free Cash Flow Margin	-	-3.08%	-0.73%	-1.49%	-4.46%	-4.62%
EBITDA	-259.16	-330.97	-190.7	-234.42	-88.27	-104.81
EBITDA Margin	-5.61%	-4.36%	-1.44%	-2.59%	-2.10%	-3.27%
D&A For EBITDA	5.74	0.58	1.51	1.37	1.46	0.96
EBIT	-264.91	-331.56	-192.21	-235.79	-89.73	-105.77
EBIT Margin	-5.73%	-4.37%	-1.46%	-2.60%	-2.14%	-3.30%
Advertising Expenses	-	0.96	10.69	25.32	2.95	2.78

Updated Oct 1, 2021. Source: S&P Global Market Intelligence. Standard template. Financial Sources.